SkylineDx United States of America Netherlands United Kingdom

New Data from PROMMIS Study Highlights the Power of SKY92 in Identifying High-Risk Multiple Myeloma Patients

View original content:https://www.prnewswire.co.uk/news-releases/new-data-from-prommis-study-highlights-the-power-of-sky92-in-identifying-high-risk-multiple-myeloma-patients-302324946.html